SEARCH
Corona Vaccine की Cocktail Dosage के खिलाफ Cyrus Poonawalla , देखिए क्यों जताई आपत्ति
Amar Ujala
2021-08-14
Views
119
Description
Share / Embed
Download This Video
Report
Corona Vaccine की Cocktail Dosage को Cyrus Poonawalla ने गलत बताया है। उन्होंने कहा कि Covishield and Covaxin की कॉकटेल डोज सही नहीं है। देखिए पूरी रिपोर्ट।
#CovishieldAndCovaxin #CocktailDosage #CyrusPoonawalla
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x83epiu" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
02:41
भारतात डिसेंबरपर्यंत येऊ शकते Covishield Vaccine | Adar Poonawalla | Serum Institute Of India
04:09
India Approves Two COVID-19 Vaccines: Oxford-Serum Institute's Covishield & Bharat Biotech's Covaxin Receives Emergency Approval From DCGI
03:50
Oxford COVID-19 Vaccine ‘70% Effective, Serum Institute Chief Adar Poonawalla Says India Could Give Nod By Year-End
02:36
कोरोना लसीबाबत मोठा खुलासा | Adar Poonawalla On Corona Vaccine | Serum Institute | India News
05:48
‘Historic moment’ Aadar Poonawalla as Serum institute dispatches COVID19 vaccine across India _ Tv9
01:51
COVID-19 Vaccine: ‘Covishield To Be Available In 73 Days? Serum Institute Of India Busts Fake News, Calls Such Reports False
02:09
Corona Vaccine India: Serum Institute ने बताया, कैसे असरदार होगी Covishield | वनइंडिया हिंदी
03:10
Two Fires At Serum Institute Of India Compound In Pune, Five Dead; Covishield Vaccine Production Unaffected; PM Modi Offers Condolences
05:27
Serum Institute Of India Ships Millions Of Covishield Vaccine Doses Across The Country Ahead Of ‘Biggest Vaccination Drive’
03:02
Coronavirus India: Serum Institute को सरकार से मिला Covishield Vaccine का ऑर्डर | वनइंडिया हिंदी
03:28
Oxford COVID-19 Vaccine: Serum Institute Begins Clinical Trials Of Covishield In Pune, India
02:28
Plasma Therapy Doesnt Reduce COVID-19 Death Risk, Says ICMR, Serum Institute Of India Gets Notice From DCGI After Oxford Coronavirus Vaccine Trial Paused